The first joint Europe-wide assessment of the drivers and impact of chemical pollution by the European Environment Agency (EEA) and the European Chemicals Agency (ECHA) has concluded that, despite progress in some areas, “more work is still needed to reduce the impact of harmful substances on human health and the environment”. Key findings include:
* The transition towards safer and more sustainable chemicals is progressing in some areas but just getting started in others
* Action by authorities and industry has supported minimising and controlling the risks from several groups of hazardous chemicals. Efforts are ongoing to increase knowledge on chemical hazards and support risk management action where needed
* There has been little evidence of progress towards eliminating substances of concern from waste and secondary materials. This is a barrier to the transition towards a more circular economy
* Emissions of certain chemicals to water and air have fallen following specific EU regulations and international actions, but further measures are needed to reach concentration levels that are not harmful for human health and the environment. Emissions from industry still lead to major damage to both
* Human biomonitoring offers the opportunity to understand exposure to chemicals from multiple sources and thus health risks associated with chemical pollution. As such, it forms a key tool to measure the effectiveness of chemicals legislation
The report established that the use of the most harmful chemicals (in carcinogenic, mutagenic and reprotoxic (CMR) chemicals) is still growing albeit slower than the overall market. More needs to be done to avoid the use of substances of concern and to implement the principles of the safe and sustainable by design (SSbD) framework. The shift in that direction must be accelerated.
Reference:
https://www.specchemonline.com/more-work-needed-safety-sustainability
Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.
A significant uptick in M&A activity in the biosimilars sector is being driven by FDA regulatory reforms, a maturing patent litigation framework and a looming patent cliff — $200 billion of branded products are facing patent expiration by 2030.
The Drewry World Container Index edged lower this week as falling Asia-Europe rates outweighed firmer pricing on the Transpacific, with carriers preparing another round of blank sailings ahead of China’s Golden Week holiday.
Diacetone Alcohol (DAA) is an aliphatic hydroxy ketone produced through the base-catalysed aldol addition of two acetone molecules. It contains both ketone and tertiary hydroxyl functionalities, offering excellent solvency and chemical reactivity.
As a high-boiling oxygenated solvent and valuable chemical intermediate, DAA finds broad application in paints and coatings, printing inks, adhesives, industrial cleaning, cosmetics, and textiles. It is also used as an intermediate in the production of mesityl oxide and MIBK. (4-methylpentan-2-one).